Involvement of the MLL/ALL-1 gene associated with multiple point mutations of the N-ras gene in acute myeloid leukemia with t(11;17)(q23;q25)

نویسندگان

  • T Naoe
  • K Kubo
  • H Kiyoi
  • R Ohno
  • Y Akao
  • J Yoshida
  • K Kato
  • S Kojima
  • T Matsuyama
چکیده

To the Editor: tion. She received combination chemotherapy and achieved complete remission. However, 1.5 years later, the AML relapsed despite the intermittent intensification, and she died of cerebral bleeding. Karyotype analysis of the blast cells at diagnosis showed 46 XX with the t( I I ; I 7)(q23;q25) translocation in 20 of 20 analyzed cells. The breakpoints of the MLL/ALL-I gene have been clustered within the BumHI 9-kb genomic fragment, which can be detected by the BumHl0.9-kbcDNA fragment’”(Fig 1). Southern blotanalysis using this probe showed two rearranged bands in the BamHI digested DNA, and one rearranged band accompanied with a relatively fainter germ line band at 5.5 kb in the EcoRV digested DNA (Fig I) , which suggested that the MLL/ALL-1 gene was disrupted within the EcoRV-BamHI 5-kb fragment and jointed presumably with a DNA fragment on 37q25. Furthermore, the blast cells at diagnosis had the multiple-point mutations of the N-rus gene.’ cDNA ofthe N-rasgene were amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) and were cloned into the M I3mpl8 vector. The presence of mutations in 90 clones was analyzed by means of oligonucleotide hybridization (Table l). Two clones containing double-loci mutations at codons 13 and 61 were detected in the same allele. Forty clonescontained each mutation at codons 12, 13, and 6 I . and the remaining 48 clones showed the wild-type of N-ras gene. Southern blot analysis of the N-ras gene Chromosome I 1 band q23 ( I lq23) is one of the most frequent disrupting regions of the chromosome translocations and deletions in various types ofleukemia, lymphomas, and myelodysplastic syndromes.’ The partner regions for the reciprocal translocations are lp32, lq21, 2p21, 4q21, 6q27, 9p22, IOp15, 14q32, 17q25, and 19~13.’ Recent studies have shown that the MLL/ALL-1 gene is involved in the t(4;l l)(q21;q23) and t(l1;19)(q23:p13) translocations of infantile acute leukemia with biphenotypic character.3-’ Furthermore, this gene also associated with t( l ; I I ) , t(6;l I ) and t(9; I 1): The MLL/ALL-I gene encodes for a human homologue of the Drosophila trithorax protein that fuses to the partner chromosome-encoded protein, producing a fusion transcriptional fact ~ r . ’ . ~ . ~ Thus, the MLL/ALL-I gene is likely to be associated with leukemogenesis in the 1 lq23 translocation. We present here a case ofacute myeloidleukemia(AML) with the t( 11;17)(q23;q25) translocation showing the rearrangement ofthe MLL/ALL-I gene associated with multiple N-ras gene mutations. A 9-year-old girl was refereed to us for AML (MI) according to the French-American-British (FAB) classification, with a leukocyte count of85 X IO’lpL, hemoglobin (Hb) 8. I g/dL, and platelets 30 X IO’lpL. She had been healthy except some episodes of viral infec-

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25).

The t(11;17) has been described in patients with acute myeloid leukemia (AML), and the AF17 gene was previously cloned as a fusion partner of the MLL gene in t(11;17)(q23;q21)-AML. We analyzed one patient with de novo AML and one with therapy-related AML with t(11;17)(q23;q25) and identified the AF17q25 gene on chromosome 17q25, a putative septin family gene, fused with MLL. AF17q25 encoded at ...

متن کامل

MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).

MLL (ALL1, Htrx, HRX), which is located on chromosome band 11q23, frequently is rearranged in patients with therapy-related acute myeloid leukemia who previously were treated with DNA topoisomerase II inhibitors. In this study, we have identified a fusion partner of MLL in a 10-year-old female who developed therapy-related acute myeloid leukemia 17 months after treatment for Hodgkin's disease. ...

متن کامل

بررسی جهش‌های ژن N-RAS در اطفال مبتلا به لوسمی لنفوبلاستیک حاد(ALL)

Background: Acute leukemia is the prevalent malignancy in pediatrics. One of the most important causing factors of acute lymphoblastic leukemia is mutations of proto oncogenes and their chang in to oncogenes. Activation of N-RAS proto-oncogene due to point mutations plays a major role in ALL malignancy. Since there was no report on the frequency of N-RAS gene mutation in Iranian pediatric AL...

متن کامل

Acute Lymphoblastic Leukemia MLL/GAS7 fusion in a pediatric case of t(11;17)(q23;p13)-positive precursor B-cell acute lymphoblastic leukemia

MLL/GAS7, resulting from t(11;17)(q23;p13), has been reported in one case of treatment-related acute myeloid leukemia (AML). We present a de novo case of t(11;17)-positive pediatric acute lymphoblastic leukemia. Fluorescent in situ hybridization and reverse transcriptase polymerase chain reaction analyses revealed an MLL/GAS7 chimera identical to the one previously described in AML. The molecul...

متن کامل

Evaluation of the CD123 Expression and FLT3 Gene Mutations in Patients with Acute Myeloid Leukemia

Background and Objective: Identification of cytogenetic and molecular changes plays an important role in acute myeloid leukemia (AML) patients. Thus, they are used in classification, prognosis and treatment of the disease. The CD123 expression and FLT3 gene mutations are also the variations that may assist in prognosis and treatment of patients with AML.Methods:</...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Blood

دوره 82 7  شماره 

صفحات  -

تاریخ انتشار 1993